BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17361763)

  • 1. The control of bovine viral diarrhoea virus in Europe: today and in the future.
    Lindberg A; Brownlie J; Gunn GJ; Houe H; Moennig V; Saatkamp HW; Sandvik T; Valle PS
    Rev Sci Tech; 2006 Dec; 25(3):961-79. PubMed ID: 17361763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of two-step vaccination in the control of bovine viral diarrhoea (BVD).
    Moennig V; Eicken K; Flebbe U; Frey HR; Grummer B; Haas L; Greiser-Wilke I; Liess B
    Prev Vet Med; 2005 Nov; 72(1-2):109-14; discussion 215-9. PubMed ID: 16169620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal risk management versus willingness to pay for BVDV control options.
    Santarossa JM; Stott AW; Humphry RW; Gunn GJ
    Prev Vet Med; 2005 Nov; 72(1-2):183-7; discussion 215-9. PubMed ID: 16169618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BVDV control and eradication in Europe--an update.
    Ståhl K; Alenius S
    Jpn J Vet Res; 2012 Feb; 60 Suppl():S31-9. PubMed ID: 22458198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress of control and prevention programs for bovine viral diarrhea virus in Europe.
    Sandvik T
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):151-69. PubMed ID: 15062480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of bovine virus diarrhoea at the herd level: reducing the risk of false negatives in the detection of persistently infected cattle.
    Laureyns J; Ribbens S; de Kruif A
    Vet J; 2010 Apr; 184(1):21-6. PubMed ID: 19157928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing economic and social pressure for the control of bovine viral diarrhoea virus.
    Gunn GJ; Saatkamp HW; Humphry RW; Stott AW
    Prev Vet Med; 2005 Nov; 72(1-2):149-62; discussion 215-9. PubMed ID: 16243404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten years of bovine virus diarrhoea virus (BVDV) control in Norway: a cost-benefit analysis.
    Valle PS; Skjerve E; Martin SW; Larssen RB; Østerås O; Nyberg O
    Prev Vet Med; 2005 Nov; 72(1-2):189-207; discussion 215-9. PubMed ID: 16213612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and control of BVD in the U.S.
    Van Campen H
    Vet Microbiol; 2010 Apr; 142(1-2):94-8. PubMed ID: 19833455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics in the epidemiology of bovine viral diarrhea virus (BVDV) of relevance to control.
    Lindberg A; Houe H
    Prev Vet Med; 2005 Nov; 72(1-2):55-73; discussion 215-9. PubMed ID: 16214248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a benefit function to assess the relative investment potential of alternative farm animal disease prevention strategies.
    Stott AW; Gunn GJ
    Prev Vet Med; 2008 May; 84(3-4):179-93. PubMed ID: 18243379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mental notes in tracking BVDV carriers].
    Laureyns J; Ribbens S; de Kruif A
    Tijdschr Diergeneeskd; 2006 May; 131(9):330-4. PubMed ID: 16711566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study in the control of bovine viral diarrhea.
    Larghi M
    Anim Health Res Rev; 2018 Dec; 19(2):125-133. PubMed ID: 30348240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perspectives on BVD eradication in Germany].
    Moennig V; Greiser-Wilke I
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):222-6. PubMed ID: 12784556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling collective effectiveness of voluntary vaccination with and without incentives.
    Rat-Aspert O; Fourichon C
    Prev Vet Med; 2010 Mar; 93(4):265-75. PubMed ID: 20022648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of bovine viral diarrhoea virus in New Zealand: a review of research progress and future directions.
    Han JH; Weir AM; Weston JF; Heuer C; Gates MC
    N Z Vet J; 2018 Nov; 66(6):273-280. PubMed ID: 30091684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccines against infection with bovine viral diarrhea virus/mucosal disease (BVDV/MD): a short overview].
    Beer M; Wolf G
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):252-8. PubMed ID: 12784561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of BVDV eradication in 'closed' cattle herds.
    Borsberry S
    Vet Rec; 2012 Jun; 170(25):652. PubMed ID: 22730499
    [No Abstract]   [Full Text] [Related]  

  • 20. Eradication programme for bovine viral diarrhoea virus in Orkney 2001 to 2008.
    Truyers IG; Mellor DJ; Norquay R; Gunn GJ; Ellis KA
    Vet Rec; 2010 Oct; 167(15):566-70. PubMed ID: 21257418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.